Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma: Cranford, New Jersey Wednesday, December 3, 2025, 16:00 Hrs [IST] Cit ...
Researchers found a way to reprogram immunity against allergies and it lasted a full year in tests -- in mice.
Citi Annual Global Healthcare Conference 2025 December 3, 2025 4:00 PM ESTCompany ParticipantsMarshall Fordyce - ...
“LYMPHIR is an important new treatment option for the CTCL community, and its launch marks the beginning of a new chapter for ...